8,820 results on '"Rotavirus Infections"'
Search Results
2. Concomitant kawasaki disease and rotavirus infection-more than just a coincidence: A case report
3. The Efficacy of Oral Rotavirus Vaccine 116E (ROTAVAC 5D) in Chilean Infants (Rota5DCHILE)
4. Phase II Clinical Trial of the Inactivated Rotavirus Vaccine
5. A Phase II Dose-ranging Study of Oral RV3-BB Rotavirus Vaccine
6. Safety and Immunogenicity Study of Recombinant Trivalent Rotavirus Subunit Vaccine in Healthy Infants and Toddlers
7. SaniVac Trial - Sanitation and Oral Rotavirus Vaccine Performance
8. A Surveillance Study on Timing and Coverage Of Rotavirus and MenB Vaccine Co-administration in Campania Region, Italy (STORM)
9. Safety Study of 2 Formulations of GSK's Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 Weeks
10. Community transmission of rotavirus infection in a vaccinated population in Blantyre, Malawi: a prospective household cohort study
11. Inference of Naturally Acquired Immunity Using a Self-matched Negative-Control Design
12. A CD22-Shp1 phosphatase axis controls integrin β7 display and B cell function in mucosal immunity.
13. Safety and Immune Response of a Rotavirus Vaccine in HIV-infected and Uninfected Children Born to HIV-infected Mothers
14. Reactogenicity, Safety and Immunological Efficacy of the Live, Pentavalent Rotavirus Vaccine in Childhood Immunization
15. Safety and Immunological Efficacy of the Pentavalent Rotavirus Vaccine - Rota-V-Aid™ (Live Attenuated Oral, Freeze-dried) at Healthy Adults Aged 18 to 45 Years.
16. Navigating Rotavirus Vaccination: A Global Perspective on Progress and Challenges
17. Ly6cLo non-classical monocytes promote resolution of rhesus rotavirus-mediated perinatal hepatic inflammation.
18. Tube Well Use as Protection Against Rotavirus Infection During the Monsoons in an Urban Setting
19. A Trial to Assess the Safety, Immunogenicity and Efficacy of a Trivalent Rotavirus P2-VP8 Subunit Vaccine in Prevention of Severe Rotavirus Gastroenteritis in Healthy Infants in Africa and India
20. To Evaluate Safety & Reactogenicity of GSK Bio's Human Rotavirus (HRV) Vaccine in Filipino Infants at Least 6 Weeks of Age at First Vaccination
21. Diagnostic accuracy of rotavirus antigen tests in children: A systematic review and meta‐analysis.
22. Safety and Preliminary Immunogenicity Study of Inactivated Vaccine for Prevention of Rotavirus Infection
23. This Study Will Evaluate the Immunogenicity, Reactogenicity and Safety of the Routine Infant Vaccines Pediarix®, Hiberix® and Prevenar 13® When Co-administered With GlaxoSmithKline (GSK) Biologicals' Liquid Human Rotavirus Vaccine (HRV) as Compared to GSK's Licensed Lyophilized Vaccine
24. A Study of Safety, Reactogenicity and Immunogenicity of HRV Vaccine in HIV Infected Infants in South Africa
25. Rotavirus
26. Evaluating strategies to improve rotavirus vaccine impact during the second year of life in Malawi
27. Heterogeneous susceptibility to rotavirus infection and gastroenteritis in two birth cohort studies: Parameter estimation and epidemiological implications.
28. Rotavirus is associated with decompensated diarrhea among young rhesus macaques (Macaca mulatta)
29. The Effects of Increased Inoculum on Oral Rotavirus Vaccine Take and Immunogenicity
30. Evaluation of Immunogenicity and Safety of Two Formulations of GSK Biologicals' Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 Weeks
31. Evaluation of an Infant Immunization Encouragement Program in Nigeria
32. Evaluation of Reactogenicity and Safety of GSK Biologicals' Rotarix (Human Rotavirus Vaccine) in Infants
33. Study to Evaluate Immunogenicity, Reactogenicity and Safety of Rotarix™ Vaccine in Korean Infants
34. Phosphorylation cascade regulates the formation and maturation of rotaviral replication factories
35. Effectiveness Study of GSK Biologicals' Rotarix TM Vaccine in Hospitalized Children
36. A Study to Evaluate Immune Response and Safety of Two Doses of GSK Biologicals' HRV Liquid Vaccine in Healthy Infants.
37. Efficacy, Safety, Reactogenicity & Immunogenicity of the Rotarix Vaccine in Japanese Infants
38. Evaluate Protective Efficacy of Diff Strengths of Human Rotavirus Vaccine After Admn of 2 Doses to Infants Aged 2 Months
39. A Study to Test 2 Doses of the HRV Vaccine in Healthy Infants.
40. Glycan recognition in globally dominant human rotaviruses.
41. Modeling environmentally mediated rotavirus transmission: The role of temperature and hydrologic factors
42. Acute Respiratory Distress Syndrome after Rotavirus Infection in a C1q Nephropathy Patient: A Case Report
43. un Identification of enteric viruses from raw water using fluoro-immuno-magnetic separation coupled to RT-PCR
44. Study to Assess the Impact of Vaccination on Hospitalizations and Outpatient Visits Due to Rotavirus Gastroenteritis
45. Evaluate Immunogenicity, Safety, and Reactogenicity of Rotavac® in Healthy Infants Aged Between 6-8 Weeks in Vietnam
46. A Phase 1 Dose Escalation Study to Examine the Safety of the P2-VP8 Rotavirus Vaccine
47. The laboratory test procedure to confirm rotavirus vaccine infection in severe complex immunodeficiency patients
48. Naturally Acquired Immunity Against Rotavirus Infection and Gastroenteritis in Children: Paired Reanalyses of Birth Cohort Studies
49. A Case of Henoch-Schonlein Purpura Associated with Rotavirus Infection in an Elderly Asian Male and Review of the Literature.
50. Rotavirus Associated Acute Gastroenteritis in the Pediatric Emergency Department: A Matched Case-control Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.